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Abstract
Background: Levels of complement regulatory proteins (CrP) on the surface of red blood cells (RBC) decrease
during severe malarial anaemia and as part of cell ageing process. It remains unclear whether CrP changes seen
during malaria contribute to the development of anaemia, or result from an altered RBC age distribution due to
suppressive effects of malaria on erythropoiesis.
Methods: A cross sectional study was conducted in the north-east coast of Tanzania to investigate whether the
changes in glycosylphosphatidylinositol (GPI)-anchored complement regulatory proteins (CD55 and CD59)
contributes to malaria anaemia. Blood samples were collected from a cohort of children under intensive
surveillance for Plasmodium falciparum parasitaemia and illness. Levels of CD55 and CD59 were measured by flow
cytometer and compared between anaemic (8.08 g/dl) and non- anaemic children (11.42 g/dl).
Results: Levels of CD55 and CD59 decreased with increased RBC age. CD55 levels were lower in anaemic children
and the difference was seen in RBC of all ages. Levels of CD59 were lower in anaemic children, but these
differences were not significant. CD55, but not CD59, levels correlated positively with the level of haemoglobin in
anaemic children.
Conclusion: The extent of CD55 loss from RBC of all ages early in the course of malarial anaemia and the
correlation of CD55 with haemoglobin levels support the hypothesis that CD55 may play a causal role in this
disorder.
Background
Anaemia is a common devastating complication of
malaria caused by Plasmodium falciparum. The patho-
genesis of malarial anaemia is complex, multifactorial
and incompletely understood. Direct destruction of
infected red blood cells (RBC) during malaria seems to
be a relatively minor contributing mechanism because
parasite densities do not correspond to the severity of
anaemia [1,2]. As a result, malarial anaemia is consid-
ered to arise mainly from defective erythropoiesis or
from removal of uninfected RBC [1].
Unusually low numbers of reticulocytes in the periph-
eral blood indicate ineffective erythropoiesis and are fre-
quent in chronic malaria cases [3]. During acute
malaria, anaemia is thought to arise mainly from the
loss of uninfected RBC [1,2] although the mechanism
for this is not completely understood. Uninfected RBC
may be prematurely removed from the circulation by
either phagocytic immune cells or complement attack.
In Kenya, children with severe malarial anaemia demon-
strated increased erythrophagocytosis as well as
decreased levels of complement regulatory proteins
(CrP) including complement receptor 1 (CR1) and decay
accelerating factor (CD55) [4]. Decreases in CrP levels
may predispose RBC to destruction by complement acti-
vation, thus contributing to the development of anae-
mia. CrPs are absolutely required to protect RBC from
spontaneous complement damage [5] and CrP deficien-
cies render RBC more susceptible to complement
damage [6,7].
Although levels of other surface molecules are known
to vary as RBC age [8-11], changes in the CD55 and
CD59 levels in relation to cell aging during malaria have
not been examined. Impaired RBC production and shor-
tened RBC survival occur during malaria, and together
have the effect of reducing the production of new RBC
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altered RBC age distributions might contribute to appar-
ent changes in CrP levels during malarial anaemia. This
study compared surface glycosylphosphatidylinositol
(GPI)-anchored complement regulatory proteins levels
on RBC of different ages in infected children with or
without recent onset of malarial anaemia.
Methods
Study population and clinical procedures
Demographic and laboratory characteristics of the study
population are presented in Table 1.
The study population included children participating
in a longitudinal birth cohort study managed by the
Mother Offspring Malaria Studies (MOMS) Project. The
study was based at Muheza Designated District Hospital
(DDH), near the north-eastern coast of Tanzania, an
area of intense malaria transmission.
Children participating in the birth cohort were exam-
ined by an assistant medical officer every two weeks
during infancy and every month thereafter; each exami-
nation included blood smear analysis. Venous blood
samples were collected at 3, 6 and 12 months of age,
then once after every six months in the second and
third years of life and during any episode of parasitae-
mia or illness. Children were treated for any malaria epi-
sode, and efficacy of treatment was confirmed one week
later by repeat blood smear. Capillary blood was drawn
into heparinized tubes for preparation of blood smears,
and venous blood for blood cell counts was drawn into
a syringe containing the anticoagulant Citrate/Phos-
phate/Dextrose. Parasites were detected by microscopic
examination of Giemsa-stained thick and thin smears
prepared from capillary or venous blood. Parasitaemia
was quantified as the number of parasitized RBC per
200 white blood cells in the thick smear, and parasite
species were determined by examination of the thin
smear. Haemoglobin levels and other haematological
parameters were determined by haematology analyzer
Cell Dyne
® 1200 (Abbott Diagnostics Division, IL, USA).
The analyses for this study involved 105 children aged
between six and 30 months. Of these, 84 children were
sequentially enrolled after being diagnosed as having
malaria and 21 healthy children served as controls.
Healthy control children were enrolled after being
proved to have normal haemoglobin levels, free from P.
falciparum infection both symptomatically and micro-
scopic blood smear examination, and had no record of
parasitaemia for at least three months prior to sampling.
Clinical malaria was defined as asexual P. falciparum
parasitaemia by blood smear coupled with symptoms
suggestive of malaria, most commonly fever ≥ 37.5°C.
Anaemia was defined as haemoglobin concentration
below 10 g/dL. Children with sickle cell anaemia
(HbSS), Glucose 6 phosphate dehydrogenase enzyme
deficiency (both hemizygous males and homozygous
female) and 3.7 kb deletion alpha-thalassemia (heterozy-
gous and homozygous) were excluded from this analysis.
Ethical issues
Women presenting at Muheza DDH for delivery were
invited to enroll their offspring in the cohort, and pro-
vided signed consent prior to the participation of their
newborns in the birth cohort study. Protocols for proce-
dures used in this study were approved by the Interna-
tional Clinical Studies Review Committee of the
Division of Microbiology and Infectious Diseases at the
US National Institutes of Health, and ethical clearance
was obtained from the Institutional Review Boards of
Seattle Biomedical Research Institute and the National
Institute for Medical Research in Tanzania.
Determination of RBC age profiles
RBC were separated into age subpopulations by a den-
sity gradient centrifugation method as described pre-
viously [12,13] with minor modifications. RBC were
separated from plasma and leukocytes by centrifugation
at 600 × g for 5 minutes. After removing the plasma
and leukocytes, RBC were washed in PBS buffer twice,
and a 100 μl blood pellet was resuspended in RPMI
1640. Percoll (Sigma-Aldrich, St. Louis, MOUSA) den-
sity gradients were used to separate RBC into fractions
of varying ages. Percoll/5% sorbitol (W/V) was prepared
by dissolving 5 g of sorbitol in 10 ml RPMI 1640 then
mixing with 90 ml of Percoll. This solution was diluted
with RPMI 1640 to make 90%, 80%, 70%, 60% and 40%
Percoll solutions, corresponding to the following densi-
ties 1.099 g/ml, 1.082 g/ml, 1.070 g/ml, 1.061 g/ml and
Table 1 Demographic characteristics of study groups
Healthy control Non anaemic Anaemic children P Value
Cases (Male/Female) N = 21 (12/9) N = 34 (16/18) N = 50 (32/18)
Haemoglobin g/dl (SD) 11.64 (1.16) 11.42 (1.68) 8.08 (1.51) < 0.0001*
Age (Months) 18.95 (11.52) 19.45 (8.4) 17.62 (6.1) 0.0936
Parasite density/200wbc) - 2884.2(3122.5) 2700.64 (3458) 0.9715
Haemoglobin level are presented as means (Standard deviation) Data on age and parasite density are presented in Median (Interquartile range) values*
Significant difference between anaemic and non anaemic children
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Page 2 of 81.046 g/ml respectively. The gradients were prepared in
15 ml plastic tubes (1 ml of each fraction), with the
highest Percoll concentration at the bottom. Thereafter,
0.1 ml packed RBC was diluted in 5 parts of RPMI 1640
then layered on top of the Percoll gradient, and centri-
f u g e da t1 0 7 5×g for 20 minutes at room temperature.
Each fraction of cells was aspirated and transferred to a
new tube, washed twice in RPMI 1640, then suspended
and pelleted by centrifugation at 600 × g for 5 minutes.
The supernatant was removed, and the pelleted cells
resuspended by adding 200 μl of RPMI 1640. The num-
ber of red cells in each fraction was counted by haema-
tology analyzer, and the cells in each age group were
calculated as proportions of the total number of cells.
Measurement of CD55 and CD59
Red blood cells were washed twice in PBS buffer supple-
mented with 1% BSA and 0.1% NaN3 then suspended in
t h es a m eb u f f e ra t1×1 0
6 cells/ml. To label CrP, the
RBC were incubated with monoclonal antibodies against
human CD55 and CD59, according to manufactures
instructions (BD Biosciences-PharMingen, USA) conju-
gated to Cyanine 5 (CY5) and Phycoerythrin (PE),
respectively. Irrelevant monoclonal antibodies of the
same isotype were used as negative controls (Molecular
Probes, USA). The samples were incubated at 4 C in the
dark for 30 minutes. The RBC were washed twice in
buffer, resuspended in PBS and analysed immediately by
flow cytometer (Flomax, Partec, Germany). The cells
were excited with 488 nm argon ion laser, and the loga-
rithmic orange (PE) and red (CY 5) fluorescences were
measured through FL2 and FL3 detectors respectively.
RBC were gated on the basis of their logarithmic ampli-
fication of the light scatter properties. One thousand
events were acquired in replicate for each sample. The
results were presented as mean fluorescence intensity
(MFI) of RBC with specific immunofluroescence above
the background fluorescence as determined by isotype
controls [4].
Detection of phosphatidylserine exposure
Annexin V-FITC apoptosis detection kit (Sigma-Aldrich)
was used for the detection of phosphatidylserine on RBC
surfaces. The cells were washed twice in PBS and then
resuspend in 1 × binding buffer (100 mM HEPES/
NaOH, pH 7.5 containing 1.4 M NaCl and 25 mM
CaCl2) at a concentration of approximately1 × 10
6 cells/
ml. Then 1 μl of Annexin V-FITC (Sigma) was added in
each 100 μl of cell suspension and mixed thoroughly by
gently vortex. The tubes were incubated at room tem-
perature for exactly 10 minutes in the dark. Thereafter,
400 ml of binding buffer was added to each tube. Analy-
sis by flow cytometer (Flomax - Partec
® - Germany) was
performed within 1 hr. The negative control was
prepared each time by following all steps for PS staining
except that the Annexin V-FITC addition step was
skipped.
Validation of the Percoll density gradient method
Percoll density gradient method was validated by asses-
sing the relationship between RBC density and age
related modifications. Blood for this purpose was
obtained from seven healthy donors, and then processed
similar to other study subjects. After density gradient
separation, each RBC fraction was analysed for the
mean corpuscular volume (MCV), level of phosphatidyl-
serine exposure to surface membranes and levels of
CD55 and CD59.
Data analysis
Statistical analysis was performed using StatView version
5.0.1 (SAS Institute Inc. Cary, NC, USA) software pack-
age. The Mann-Whitney test was used to test differ-
ences between groups and Spearman rank correlation to
examine relationships between variables. Multivariate
linear regression analyses were used to determine the
relationship between parasite density, CrP levels and
child’sa g e .AP value ≤ 0.05 was considered statistically
significant.
Results
Study population and characteristics
Demographic and laboratory characteristics of the study
population are presented in Table 1.
RBC Age profiles
In most samples the cells separated into four distinct
bands following centrifugation on Percoll density gradi-
ents and were designated as young for top band (60%
Percoll solution), mature for second band from top
(70% Percoll solution), old for third band form top (80%
Percoll solution), and very old for the bottom band
(90% Percoll solution) subsets [10]. An additional layer
containing mostly leukocytes, infected RBCs and few
reticulocytes as assessed by microscopy was observed at
the 40% Percoll solution layer in few samples, but this
heterogeneous pool was not included in the current
analysis.
Analysis of blood obtained from healthy subjects to
validate the Percoll density method showed that MCV
measurements decreased as cells increased in density,
the difference between young cells and oldest fraction
was statistically significant (Table 2). Similarly, the mean
fluorescence intensities for CD55 and CD59 decreased
with increasing density. Annexin V binding was higher
in the bottom band (older RBC subsets) than in the
younger populations (Table 2), suggesting that the expo-
sure of endogenous phosphatidyiserine on RBC surface
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fraction as reported previously [10].
Overall analysis of RBC age profile from malaria
infected children indicated that the mean proportional
of cells in the top band was 20.82% xs(± 19.3), in the
second band was 50.56% (± 17.69) in the third band was
23.4% (± 15.72) and 5.62% (± 4.52) in the bottom band.
Compared to children in other groups, blood obtained
from anaemic donors displayed a significant increase in
the proportion of young RBC, and non-significant
changes in other subpopulations (Figure 1). Neither the
child’s age nor the parasite density correlated with RBC
age profile (Spearman rank test, P > 0.05 for all compar-
isons in both anaemic and non-anaemic groups).
Cytofluorometry
Overall levels of CD55 but not CD59 were higher in the
healthy controls than in other groups but this difference
was only significant for the anaemic malaria cases.
CD55 MFI levels were significantly higher in the healthy
control group in all RBC subsets when compared to
anaemic malaria cases i.e. median (IQR = 25-75%) for
Table 2 Parameters used to validate the age-density relationship in RBC fractions separated by Percoll density
gradient method
Erythrocyte Age
Fraction
Density
g/ml
%o f
cells
MCV PS- MFI CD55- MFI CD59- MFI
Mean ±
SD
%
change
P Mean ±
SD
%
change
P Mean ±
SD
%
change
P Mean ±
SD
%
change
P
Young 1.061 23.5 ±
26.64
73.86 ±
1.29
0 NA 1.36 ±
0.182
0 NA 2.55 ±
0.512
0 NA 3.39 ±
0.775
0N A
Mature 1.07 44.37 ±
18.53
73.43 ±
1.39
0.58 0.1 1.43 ±
0.088
5.15 0.1416 2.11 ±
0.568
17.25 0.139 3.18 ±
0.692
6.19 0.035
Old 1.082 25.86 ±
15.99
73.00 ±
1.41
1.64 0.08 1.56 ±
0.177
14.71 0.1312 1.94 ±
0.617
23.92 0.114 3.02 ±
0.564
10.91 0.023
Very old 1.099 6.41 ±
7.94
72.29 ±
1.6
2.13 0.01 1.67 ±
0.23
22.79 0.0027 1.89 ±
0.408
25.88 0.008 2.59 ±
0.475
23.59 0.0017
MCV - Mean corpuscular volume, PS- Phosphatidylserine, MFI = Mean Fluorescence Intensity
Figure 1 Levels of young RBC increase during new onset malarial anaemia. RBC of different ages (subsets) presented as a proportion of
total RBC count. Blood was obtained from children with malarial anaemia (open boxes) and from non-anaemic infected children (shaded boxes),
and compared for differences in proportions of RBC at different ages. Each box represents the interquartile range (25-75%) of values, the
whiskers represent 10% and 90% values, the middle line represents median value and the circles represent patients who fell outside the 10%
and 90% range.
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Page 4 of 8young [2.52 (0.36) versus 2.15(0.8), P = 0.0074]; mature
[2.03 (0.46) versus 1.83 (0.44), P = 0.0026]; old [1.82
(0.47) versus 1.65 (0.33), P = 0.0327] and very old [1.67
(0.38) versus 1.69 (0.38), P = 0.0399] but not to the non-
anaemic malaria cases i.e. median (IQR = 25-75%) for
young [2.52 (0.36) versus 2.28(0.94), P = 0.2592]; mature
[2.03 (0.46) versus 2.1(0.68), P = 0.4356]; old [1.82 (0.47)
versus 1.87(0.34), P = 0.9791] and very old [1.67 (0.38)
versus 1.75(0.29), P = 0.3080]. CD59 levels were low dur-
ing malaria compared to normal controls but the differ-
ences were not significant for all RBC subsets.
Levels of CD55 and CD59 decreased progressively as
RBC aged, in all children. CD55 levels were lower in
anaemic compared to non-anaemic children for all RBC
age subsets, and these differences were significant for all
except the very old RBC subset (Figure 2). CD59 did
not differ significantly between anaemic and non-anae-
mic children in any RBC subset (Figure 3).
CD55 levels correlated significantly with the level of
haemoglobin in anaemic (Spearman rank test: young
RBC, r = 0.506, P = 0.001; mature RBC, r = 0.421, P =
0.0063; old RBC, r = 0.526, P = 0.0008; very old RBC, r
=0 . 3 7 5 ,P = 0.0246) but not in non-anaemic children
with malaria. CD59 level did not correlate with haemo-
globin in either group of children.
CrP levels did not vary with child’sa g e .C D 5 5b u tn o t
CD59 levels were negatively associated with parasite den-
sity. The relationship of CD55 to parasite density was sig-
nificant for both anaemic (r = -0.386; P = 0.0069) and
non-anaemic populations (r =- 0 . 4 6 9 ;P = 0.0063). Multi-
variate linear regression analyses for parasite density,
CD55 levels and child’s age as independent variables, and
haemoglobin level as the dependent variable indicated
that decreases in CD55 was associated with the odds (OR
95% CI) for low haemoglobin levels of 0.19 (0.05-0.83).
Discussion
The results confirm previous findings that CD55 levels
on the surface of RBC are lower in children with malar-
ial anaemia [4], and in addition indicate that CD55 loss
begins early in the course of disease and affects RBC of
all ages. It is also shown that CD55 and CD59 levels
decrease progressively as RBC age. Altered RBC age pro-
files during P. falciparum infections could therefore
modify complement regulatory proteins (CrP) levels, but
specifically do not account for the decrease in CrP dur-
ing early malarial anaemia. The correlation between
CD55 and haemoglobin levels in anaemic children sug-
gests that CD55 loss may at least partially mediate the
disease.
Figure 2 CD55 levels decrease on RBC of all ages during new onset malarial anaemia. Levels of CD55 on the surface of RBC obtained
from children infected with P. falciparum with (open boxes) or without (shaded boxes) anaemia. Each box represents the interquartile range (25
-75%) of values, the whiskers represent 10% and 90% values, the middle line represents median value and the circles represent patients who fell
outside the 10% and 90% range. CD55 levels differed significantly on the basis of RBC age and anaemia status. P value indicates significance of
relationship to anaemia status.
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erate anaemia. Children in the cohort were monitored
intensively with routine blood smears, clinical examina-
tions and prompt treatment in case of illness, and there-
fore chronic malaria cases were unlikely. Significant
increase in number of young RBC in anaemic children
suggests body’s attempt to correct the reduction in cell
mass resulting from malaria infection, and also suggests
that these cases were acute and not chronic episodes
[14]. Earlier studies focused on hospitalized children
with severe malarial anaemia and presumably many of
these were chronic cases [4]. Although CD55 levels
w e r ef o u n dt ob eh i g h e ri ny o u n gR B C ,t h ei n c r e a s ei n
the fraction of young RBC during malarial anaemia in
this cohort did not lead to an overall increase of CD55
levels. RBC of all ages had lower CD55 levels in anaemic
versus non-anaemic children, suggesting that an active
process may be removing CD55 from RBC in cases of
malarial anaemia.
Red blood cells were separated into fractions of differ-
ent ages using Percoll density gradients method. Density
gradient separation is a well validated technique which
yields distinct cell populations with progressive shift in
the cell age with density, and differ by physical and bio-
chemical properties [15-17]. Decrease in the mean cor-
puscular volume, expression of GPI-anchored
glycoproteins (CD55 and CD59) and increased exposure
of phosphatidylserine (PS) on the external leaflet of cell
membranes are related to the RBC aging process
[10-18]. Indeed, in normal donor blood samples, there
was a decrease in MCV, CD55 and CD59 inversely
r e l a t e dt oR B C sd e n s i t y .T h e se observations, together
with the increased exposure of phosphatidylserine (PS)
in the more dense RBCs, supports the notion that in
density -separated subsets, an enrichment of young,
mature, old and very old RBCs subsets was attained.
Apparently, this is the first study to show variations in
CD55 and CD59 levels in relation to RBC age during
malaria. Earlier study reported a progressive decrease in
CD55 and CD59 levels with RBC age in healthy donors
[18,19]. Reductions in CD55 and CD59 molecules dur-
ing RBC aging in healthy individuals suggest that non-
pathological mechanisms exist to mediate CrP loss
throughout RBC life. These mechanisms are not fully
understood, although several studies suggest that CrP
molecules are lost from RBC through vesicle formation
and extrusion from the cell surface [11-20]. Additional
mechanisms may include proteolytic cleavage of CrP
during transport and clearance of immune complexes
from the RBC surface in the liver and spleen [8]. How-
ever, the loss of RBC surface molecules during malarial
anaemia appears to be a selective process. CD55 but not
Figure 3 CD59 levels do not change significantly on RBC of all ages during new onset malarial anaemia. Levels of CD59 on the surface
of RBC obtained from children infected with P. falciparum with (open boxes) or without (shaded boxes) anaemia. Each box represents the
interquartile range (25 -75%) of values, the whiskers represent 10% and 90% values, the middle line represents median value and the circles
represent patients who fell outside the 10% and 90% range. CD59 levels varied significantly on the basis of RBC age but not anaemia status. P
value indicates significance of relationship to anaemia status.
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It is suggested that an active process separate from phy-
siological cell ageing may be taking place during malaria
that preferentially removes specific RBC surface
molecules.
Alternatively the same mechanism responsible for
physiological loss may be taking place, but at an acceler-
ated rate for CD55. A process resembling transfer reac-
tion of CR1 has been proposed to explain the loss of
CD55 on RBC during malaria [21]. During transfer reac-
tion immune complexes are removed from RBC surfaces
by phagocytes. In healthy individuals, RBC act as passive
shuttles for the transport of complement-coated
immune complexes from the circulation to the reticu-
loendothelial phagocytes in the liver and spleen.
The correlation between CD55 and haemoglobin as
observed in this study suggests that CD55 depletion
contribute to RBC loss during malarial anaemia. Ery-
throphagocytosis resulting from C3b deposition on RBC
could explain the concomitant decrease of CD55 and
haemoglobin. Severe malarial anaemia is associated with
elevated levels of circulating immune complexes [22,23],
which could be adsorbed by CD55 and subsequently
transferred to macrophages [21]. The loss of CD55 dur-
ing this process could compromise its regulatory func-
tion and allow the deposition of opsonin C3b on RBC
[24,25], leading to increased RBC destruction by the
phagocytes in the reticuloendothelial tissues. Comple-
ment binding to RBC has been reported to be associated
with macrophage activation and reduced haemoglobin in
P. falciparum malaria [26].
Alternatively, direct lysis of RBC by membrane attack
complex (MAC) could explain the concomitant decrease
of CD55 and haemoglobin, but seems less likely. Children
with severe malarial anaemia have been reported to have
low levels of CR1 and CD55 [3]. Such deficiencies would
likely render the RBC vulnerable to complement attack,
especially during complement activation which is com-
mon during malaria [27]. However, CD59 did not
decrease significantly during anaemia episodes in this or
earlier studies [4], which imply that complement-
mediated lysis is not the likely mechanism for RBC loss
during malaria. CD59 is a principal regulatory protein of
complement attack [17]. Weisner et al [28] found that
despite the activation of all lytic complement factors, no
complement-mediated lysis of RBC occurred in the pre-
sence of functional intrinsic CD59. Because CD59 levels
do not change significantly during malarial anaemia, this
probably limits complement-mediated lysis.
The differential loss of CD55 and CD59 may be
related to their different roles in protection from com-
plement attack. Activation of complement occurs in a
step-wise fashion, and each regulatory protein acts at a
different step in the cascade. CD55 acts at the initial
enzymatic step to prevent the activation of C3 to C3b
by accelerating the dissociation of the C3 convertase
C4-2a and C3bBb [28-30]. CD59 prevents formation of
polymeric C9 complex at the final step of MAC assem-
bly [31]. At least during acute malarial anaemia, CR1
and CD55 may sufficiently regulate the complement cas-
cade to limit formation of MAC, thereby consuming
CD55 and sparing CD59.
Demonstration of higher amounts of C3 activation
and degradation fragments bound to the RBCs of the
anaemic children and an inverse correlation with CD55
would be another approach to support the hypothesis
that CD55 loss supports the causal role in malarial anae-
mia. Moreover, demonstration of C3b on the CD55 low
cells, would argue that sublytic C5b-9 induced the ecto-
cytosis of infected and bystander cells, which resulted in
the preferential loss of CD55 over CD59. This phenom-
enon was not explored in the current study, but earlier
studies by other researchers did demonstrate an increase
in C3b deposition on low red cell CR1 and CD55 levels
in children with severe malarial anaemia [24,25].
Conclusions
Reductions in CD55 during malarial anaemia are evident
in RBC of all ages, correlate with haemoglobin level, and
develop early in the course of disease. Although the
RBC age distribution changes during malarial anaemia,
and CD55 levels decrease as RBC age, these changes do
n o ta c c o u n tf o rt h eC D 5 5l o s ss e e ni nc h i l d r e nw i t h
new onset disease. Taken together, the results support
the hypothesis that CD55 loss may play a causal role in
malarial anaemia. It is suggested that the loss of CD55
during malaria compromises the complement regulatory
function thereby allows the deposition of opsonin C3b
on RBC leading to increased erythrophagocytosis and
anaemia.
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